Refine your search

Content type
Tags
Firm name
Author
Jurisdiction
Language

753 results found

Article
Ask Lexy

Mintz | USA | 20 Nov 2023

The LDT Debate: Unpacking Public Responses to FDA’s Proposed Rule

The U.S. Food and Drug Administration (FDA) recently released a proposed rule that would seek to regulate laboratory developed tests (LDTs) as…
Article
Ask Lexy

Duane Morris LLP | USA | 8 Nov 2023

Breaking News- FDA Pushes Back Enforcement Deadline for MoCRA Facility Registration and Product Listing Requirements to July 1, 2024

Today, FDA announced updated guidance regarding its MoCRA rollout. FDA does not intend to enforce the requirements related to cosmetic product…
Commentary
Ask Lexy

Baker McKenzie | USA | 20 Sep 2023

Legal makeover guide for complying with new cosmetic regulations under MoCRA: part two

This article is the second in a series on cosmetics and delves into the good manufacturing practices (GMP) regulations that the Food and Drug Administration (FDA) plans to establish for cosmetic products. This article provides an overview of some of the GMP frameworks shared by the FDA during a listening session, as well as an overarching commentary from the industry.
Article
Ask Lexy

Bergeson & Campbell PC | USA | 7 Sep 2023

EPA Posts Resources on Rule to Accelerate Use of PIPs

The U.S. Environmental Protection Agency announced on August 4, 2023, that it is providing resources to help biotechnology developers exercise the…
Article
Ask Lexy

Reed Smith LLP | USA | 6 Sep 2023

SDNY Dismisses Economic Injury Class Action Based on Express OTC Preemption

Patora v. Vi-Jon, LLC, 2023 U.S. Dist. LEXIS 153421 (S.D.N.Y. Aug. 30, 2023), is a typical express preemption decision resulting in dismissal of a…
Article
Ask Lexy

Duane Morris LLP | USA | 7 Aug 2023

FDA Issues Long-Awaited Draft Guidance for Industry on Registration and Listing of Cosmetic Product Facilities and Products Under MoCRA

MoCRA’s long-awaited rollout continues as today FDA released draft guidance to assist persons submitting cosmetic product facility registrations and…
Article
Ask Lexy

Mintz | USA | 18 Jul 2023

Those Aren’t Doritos: FTC and FDA Send Warning Letters to Companies Marketing Delta-8 Infused Munchies

The Federal Trade Commission’s (FTC) recent press release marks a continuation in government action against manufacturers of products infused with…
Article
Ask Lexy

Bergeson & Campbell PC | USA | 31 May 2023

EPA Issues Final Rule to Accelerate Use of Plant-Incorporated Biotechnologies

On May 31, 2023, the U.S. Environmental Protection Agency (EPA) released a final rule exempting a class of plant-incorporated protectants (PIP)…
Article
Ask Lexy

Reed Smith LLP | USA | 12 May 2023

Ninth Circuit: Call a Spray a Spray - Butter Substitute Labeling Claims Preempted by the FDCA

We start with the usual poodle report - actually with a comment that these may be drawing to a close, as Luca is only a few points from finishing his…
Commentary
Ask Lexy

Baker McKenzie | USA | 10 May 2023

FDA issues guidance on predetermined change control plans for AI/ML-enabled device software functions

The Food and Drug Administration (FDA) recently issued draft guidance for manufacturers whose medical devices use machine learning (ML) technologies to improve patient care. Through the draft guidance, the FDA intends to provide a least burdensome approach to support iterative improvements to ML-enabled device software functions through modifications, while continuing to provide a reasonable......
Previous page 1 2 3 ...